UKOM Sp.PD

UKOM Sp.PD — Uji Kompetensi Dokter Spesialis Penyakit Dalam (Indonesia)

Endokrin Metabolik DiabetesEnglish
Exam overview

Practice session

A 56-year-old male with a 7-year history of type 2 diabetes mellitus is admitted following an elective coronary stent placement for stable angina (confirmed atherosclerotic cardiovascular disease / ASCVD). His current medications include metformin 1,000 mg twice daily. Recent laboratory testing reveals: HbA1c 7.6%, eGFR 68 mL/min/1.73 m2, and BMI 29 kg/m2. According to the Indonesian Endocrinology Society (PERKENI) and ADA/EASD 2024 consensus guidelines, which class of glucose-lowering medication should be added to metformin as a preferred first-line component for cardioprotection, regardless of his baseline HbA1c?

Loading your practice session…